HOSPIRA INC
HSP
HSP was delisted on the 2nd of September, 2015.
452 hedge funds and large institutions have $9.53B invested in HOSPIRA INC in 2014 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 131 increasing their positions, 155 reducing their positions, and 29 closing their positions.
318% more call options, than puts
Call options by funds: $9.57M | Put options by funds: $2.29M
121% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 29
17% more capital invested
Capital invested by funds: $8.15B → $9.53B (+$1.38B)
7% more funds holding
Funds holding: 424 → 452 (+28)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
15% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 155
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.2M |
| 2 |
B
Baird
Milwaukee,
Wisconsin
|
+$41.9M |
| 3 |
Millennium Management
New York
|
+$41.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$31.2M |
Top Sellers
HSP Hedge Fund Activity: Q4 2014 in Review
452 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in HOSPIRA INC (HSP) for Q4 2014, worth a combined $9.53B — up 17% from $8.15B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new HSP positions and 29 closed out — a net gain of 35 holders — while 131 added to existing stakes and 155 trimmed.
The largest buyer was Vanguard Group, adding an estimated $44.2M. The largest seller was Cramer Rosenthal McGlynn, cutting an estimated $83.5M.
- 452 institutional investors held HOSPIRA INC (HSP) as of Q4 2014, up from 424 in Q3 2014.
- Funds reported $9.53B of HOSPIRA INC stock for Q4 2014, up 17% quarter-over-quarter.
- 64 funds opened new HOSPIRA INC positions in Q4 2014 and 29 closed out, a net change of +35 holders.
- The largest HOSPIRA INC buyer in Q4 2014 was Vanguard Group, an estimated $44.2M added.
- The largest HOSPIRA INC seller in Q4 2014 was Cramer Rosenthal McGlynn, an estimated $83.5M sold.
Based on aggregated 13F filings for Q4 2014.